Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes ...

The keto diet is considered a low-carb diet. It restricts high-calorie foods in favor of nutritious fats and proteins. Find ...

Other medications called SGLT2 inhibitors (gliflozins) may increase the risk of a potentially fatal condition called diabetic ketoacidosis. The medication, in combination with another trigger such as ...

Key growth drivers include advancements in point-of-care testing and integrated monitoring devices. The U.S. leads the market ...

Abnormal myocardial substrate utilization, neurohormonal activation, interstitial fibrosis, coronary microvascular dysfunction, and metabolic inflammation have all been implicated in the development ...

causing a potentially deadly condition called diabetic ketoacidosis. Type 2 diabetes requires constant management. First, it’s important to check your blood sugar regularly to make sure it’s ...

It became apparent that Kerry was suffering from diabetes ketoacidosis and needed to go to hospital to be treated. If Liam hadn’t found Kerry in that moment, John would’ve sent her home ...

While Mitolyn is not a magic pill, it is a metabolic catalyst that helps the body burn fat efficiently without dangerous stimulants. >>Want To Burn Fat Naturally Without Stimulants? Discover How ...

Cardio-kidney metabolic (CKM) syndrome represents a complex and circular interplay of cardiovascular, renal, and metabolic dysfunctions, significantly contributing to global morbidity and mortality.

Preoperative SGLT2 inhibitor use was not associated with an increased risk for postoperative diabetic ketoacidosis among patients with type 2 diabetes. Use of sodium-glucose cotransporter 2 ...

Individuals with diabetes are susceptible to cardiac dysfunction and heart failure, potentially resulting in mortality. Metabolic disorders frequently occur in patients with diabetes, and diabetes ...